Valion Bio Celebrates Grand Opening of Velocity Bioworks Biomanufacturing Facility in San Antonio, Anchoring Domestic Production of Entolimod™
Valion Bio celebrated the grand opening of its wholly-owned subsidiary Velocity Bioworks in San Antonio, marking the activation of its domestic manufacturing capabilities for lead asset Entolimod. The facility employs approximately 45 staff and positions the company to secure U.S. government contracts for radiation countermeasures by controlling its end-to-end supply chain.
Key figures
- Employee count
- 45
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.